Director Kim Lorence H. was granted 1,191 shares, increasing direct ownership by 2% to 74,281 units (SEC Form 4)
4 - Revolution Medicines, Inc. (0001628171) (Issuer)
Live Feed
Delayed 3mAnalyst · Insider · Buys · SEC · FDA
Signed out · 3-min delay · Sign up for real-time
- SEC Form 3 filed by new insider Skovronsky Daniel
3 - ILLUMINA, INC. (0001110803) (Issuer)
- Amendment: SEC Form SCHEDULE 13D/A filed by Central Plains Bancshares Inc.
SCHEDULE 13D/A - Central Plains Bancshares, Inc. (0001979332) (Subject)
- SEC Form 4 filed by See Explanation of Responses Bvf Partners L P/Il
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Borisy Alexis was granted 1,191 shares, increasing direct ownership by 0.05% to 2,340,075 units (SEC Form 4)
4 - Revolution Medicines, Inc. (0001628171) (Issuer)
- Director Stovsky Richard P was granted 2,144 shares, increasing direct ownership by 8% to 29,562 units (SEC Form 4)
4 - ENCORE CAPITAL GROUP INC (0001084961) (Issuer)
- Chief Executive Officer Reicin Alise covered exercise/tax liability with 924 shares, decreasing direct ownership by 0.30% to 310,623 units (SEC Form 4) to cover taxes
4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- Director Barker Thorold was granted 16 units of 2025 Annual Restricted Stock Units, increasing direct ownership by 0.97% to 1,665 units (SEC Form 4)
4 - Moelis & Co (0001596967) (Issuer)
- Director Olle Laura was granted 2,144 shares, increasing direct ownership by 6% to 37,168 units (SEC Form 4)
4 - ENCORE CAPITAL GROUP INC (0001084961) (Issuer)
- Chief Executive Officer Eberwein Jeffrey E. bought $55,765 worth of Common Stock. (5,000 units at $11.15), increasing direct ownership by 0.45% to 1,115,714 units (SEC Form 4)
4 - Star Equity Holdings, Inc. (0001210708) (Issuer)
- Director Shropshire Kenneth was granted 21 units of 2024 Annual Restricted Stock Units, was granted 18 units of 2025 Annual Restricted Stock Units and was granted 1 units of 2025 Elective Restricted Stock Units, decreasing direct ownership by 98% to 54 units (SEC Form 4)
4 - Moelis & Co (0001596967) (Issuer)
- Director Monaco Michael P was granted 2,144 shares, increasing direct ownership by 5% to 42,256 units (SEC Form 4)
4 - ENCORE CAPITAL GROUP INC (0001084961) (Issuer)
- Director Worrell Laila was granted 20 units of 2024 Annual Restricted Stock Units, was granted 17 units of 2025 Annual Restricted Stock Units and was granted 5 units of 2025 Elective Restricted Stock Units, decreasing direct ownership by 77% to 480 units (SEC Form 4)
4 - Moelis & Co (0001596967) (Issuer)
- SEC Form 4 filed by Vice Chairman, MD Cantor Eric
4 - Moelis & Co (0001596967) (Issuer)
- Director Angela A. Knight was granted 2,144 shares, increasing direct ownership by 9% to 26,475 units (SEC Form 4)
4 - ENCORE CAPITAL GROUP INC (0001084961) (Issuer)
- SEC Form 4 filed by General Counsel, Secretary Watanabe Osamu R.
4 - Moelis & Co (0001596967) (Issuer)
- SEC Form 4 filed by Principal Accounting Officer Riehl Nick
4 - Moelis & Co (0001596967) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Pilcher Ciafone Katherine
4 - Moelis & Co (0001596967) (Issuer)